Acute Myocardial Injury of Patients with Coronavirus Disease 2019

Abstract

Background: Since the outbreak of the Coronavirus Disease 2019 (COVID-19) inChina, respiratory manifestations of the disease have been observed. However, as a fatal comorbidity, acute myocardial injury (AMI) in COVID-19 patients has not been previously investigated in detail. We investigated the clinical characteristics of COVID-19 patients with AMI and determined the risk factors for AMI in them. Methods:We analyzed data from 53 consecutive laboratory-confirmed and hospitalized COVID-19 patients (28 men, 25 women; age, 19-81 years). We collected information on epidemiological and demographic characteristics, clinical features, routine laboratory tests (including cardiac injury biomarkers), echocardiography, electrocardiography, imaging findings, management methods, and clinical outcomes.Results: Cardiac complications were found in 42 of the 53 (79.25%) patients: tachycardia (n=15), electrocardiography abnormities (n=11), diastolic dysfunction (n=20), elevated myocardial enzymes (n=30), and AMI (n=6). All the six AMI patients were aged >60 years; five of them had two or more underlying comorbidities (hypertension, diabetes, cardiovascular diseases, and chronic obstructive pulmonary disease). Novel coronavirus pneumonia (NCP) severity was higher in the AMI patients than in patients with non-definite AMI (p<0.001). All the AMI patients required care in intensive care unit; of them, three died, two remain hospitalized.Multivariate analyses showed that C-reactive protein (CRP) levels, NCP severity, and underlying comorbidities were the risk factors for cardiac abnormalities in COVID-19 patients.All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Vitamin D Sufficiency Enhances Differentiation of Patient-Derived Prostate Epithelial Organoids

“…In colon cancer cell lines and mouse colon tissue, 1,25D inhibited the Wnt pathway by decreased nuclear β-catenin and increased cellular differentiation (Aguilera et al, 2007;Groschel et al, 2016;Larriba et al, 2013). Similar results of β-catenin by vitamin D metabolites were observed in Kaposi's sarcoma (Tapia et al, 2020) and renal cell carcinoma (Xu et al, 2020).…”

Is ethnicity linked to incidence or outcomes of covid-19?

“…Interest has also focused on the possibility of ethnic differences in the the expression of angiotensin converting enzyme 2 (the host receptor for SARS-CoV-2),12 and risk of both acute kidney injury13 and cardiac complications14 because of a higher prevalence of cardiovascular risk factors in ethnic minority populations.…”

Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain

“…The virus not only infects the epithelial cells, but also the resident, infiltrating, and circulating immune cells. The infected circulating immune cells carry the virus to other organs causing the extrapulmonary symptoms, including fever, myalgia, fatigue and kidney dysfunctions [35], acute myocardial injury [36], CNS and PNS symptoms [5] and maybe gastrointestinal symptoms. It is possible that other pathways exist for the virus to infect CNS, such as the viral RNA in the plasma directly infect the endothelial cells of the BBB with an unknown mechanism [37].…”